XML 18 R9.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Jan. 28, 2023
Jan. 29, 2022
Operating activities    
Net loss $ (15,694) $ (11,397)
Adjustments to reconcile net loss from operations to cash provided by (used in) operating activities:    
Depreciation and amortization 48,109 47,437
Loss (income) from equity method investments 2,190 (799)
Loss on deconsolidation of previously controlled subsidiary 189  
Amortization of debt issuance costs 634 386
Provision for doubtful accounts 5 (20)
Other non-cash expense, net 935 440
Non-cash lease expense 5,866 5,033
Loss on foreign currency transactions 38 34
Unrealized loss on available-for-sale equity securities, net 1,798  
Deferred income taxes (1,250) (1,195)
Stock-based compensation 7,108 3,957
Loss on disposal of property and equipment 1,193 5,063
Amortization of debt securities discount 125 117
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable 6,847 21,901
Unbilled receivables and retentions (5,098) (25,597)
Inventories (39,324) (21,590)
Income taxes receivable (9,388) (26,208)
Prepaid expenses and other assets (3,114) 1,789
Accounts payable 7,789 (10,720)
Other liabilities (157) (11,807)
Net cash provided by (used in) operating activities 8,801 (23,176)
Investing activities    
Acquisition of property and equipment (10,116) (17,064)
Equity method investments (2,774) (6,884)
Equity security investments (5,100)  
Business acquisitions, net of cash acquired (5,105) (46,150)
Proceeds from deconsolidation of previously controlled subsidiary, net of cash deconsolidated (635)  
Redemptions of available-for-sale investments 25,945 35,851
Purchases of available-for-sale investments (1,326) (2,987)
Other   225
Net cash provided by (used in) investing activities 889 (37,009)
Financing activities    
Principal payments of term loan (22,500) (7,500)
Holdback and retention payments for business acquisition   (5,991)
Proceeds from shares issued, net of issuance costs 20,104  
Tax withholding payment related to net settlement of equity awards (853) (1,176)
Exercise of stock options 868 2,776
Other (21) (23)
Net cash used in financing activities (2,402) (11,914)
Effects of currency translation on cash and cash equivalents 695 (613)
Net increase (decrease) in cash, cash equivalents, and restricted cash 7,983 (72,712)
Cash, cash equivalents and restricted cash at beginning of period 77,231 157,063
Cash, cash equivalents and restricted cash at end of period 85,214 84,351
Cash paid, net during the period for:    
Income taxes 1,192 1,923
Interest 5,697 3,465
Non-cash activities    
Unrealized (gain) loss on available-for-sale investments, net of deferred tax expense of $0 and $1 for the nine months ended January 28, 2023 and January 29, 2022, respectively (26) 6
Change in foreign currency translation adjustments 1,433 (3,771)
Issuances of inventory to property and equipment, ISR in-service assets 4,677 16,680
Acquisitions of property and equipment included in accounts payable $ 731 $ 626